Clinical Oncology
Volume 22, Issue 8 , Pages 621-622 , October 2010

Introduction to the Special Issue on the Technology of Radiotherapy

  • W.P.M. Mayles

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: W.P.M. Mayles, Physics Department, Clatterbridge Centre for Oncology NHS Foundation Trust, Bebington, Wirral, Merseyside CH63 4JY, UK. Tel/Fax: 044-151-604-7391.

Received 10 June 2010 ,Accepted 29 June 2010.

References 

  1. Suit HD. The American Society of Therapeutic Radiologists Presidential Address: october 1981. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer. 1981;50:1227–1234
  2. Department of Health. The National Radiotherapy Advisory Group’s report “Radiotherapy: developing a world class service for England” Department of Health, 2007. Available at: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_074576.pdf (accessed 8 June 2010)
  3. Department of Health. National Radiotherapy Advisory Group Radiotherapy Technical Development Subgroup advice to NRAG Department of Health, 2007. Available at: http://www.cancer.nhs.uk/documents/nrag_files/technology%20subgroup%20report%20nov06%20-%20fin.pdf (accessed 8 June 2010).
  4. Williams MV, Cooper T, Mackay R, Staffurth J, Routsis D, Burnet N. The implementation of intensity-modulated radiotherapy in the UK. Clin Oncol 2010;22:623–628.
  5. Ibbott GS, Followill DS, Molineu HA, Lowenstein JR, Alvarez PE, Roll JE. Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials. Int J Radiat Oncol Biol Phys. 2008;71:S71–S75
  6. MacKay RI, Staffurth J, Poynter A, Routsis D. UK guidelines for the safe delivery of intensity-modulated radiotherapy. Clin Oncol 2010;22:629–635.

PII: S0936-6555(10)00244-X

doi: 10.1016/j.clon.2010.06.019

Clinical Oncology
Volume 22, Issue 8 , Pages 621-622 , October 2010

Article Tools